Upload
brock-farra
View
218
Download
1
Tags:
Embed Size (px)
Citation preview
SAVING LIVES AND CREATING
IMPACT
EU investment in poverty-related neglected diseases
• Levels of funding• Nature of funding
• Health impact• Economic impact• Research capacity
• Jobs created• Leveraged
investment• Scientific
excellence
• Industrial competitiveness
• Health in the EU
• Integration
Growth and competitiveness in the EU
Health and prosperity in developing countries
EU Investment in PRND R&D
2How have developing countries benefitted?
3What is the return on investment for Europe?
= +
1What has the EU invested in PRND R&D?
The EU invests €341 million a year in PRND R&D
15% OF ALL FUNDING FOR PRND R&D
1What has the EU invested in PRND R&D?
Top Funders €93
m
1st EC
€87m
2nd UK
€53m3rd
France
1What has the EU invested in PRND R&D?
Sweden0.0054%
UK0.0049%
Ireland0.0047%
EU0.0024%
Finland0.0004%
Denmark0.0042%
France0.0013%
Luxembourg0.0032%
Belgium0.0016%
Netherlands0.0035% Germany
0.0007%
Italy0.0002%
Spain0.0013%
Member State Funding by GDP
USA0.01%
Brazil0.0017%
India0.0017%
1What has the EU invested in PRND R&D?
MDG 1Eradicate Extreme Poverty and Hunger
MDG 2Achieve Universal Primary Education
MDG 3Promote Gender Equality and Empower Women
MDG 4Reduce Child Mortality
MDG 5Improve Maternal Health
MDG 6Combat HIV/AIDS, Malaria and other diseases
MDG 7Ensure Environmental Sustainability
MDG 8A Global Partnership for Development
Pharmaceutical Innovation
2How have developing countries benefitted?
EU investment has contributed to the creation of 43 new PRND products
2How have developing countries benefitted?
MALARIA
KEY PHARMACEUTICAL
INNOVATIONS
1.COARTEM
2.ASAQ3.EUARTES
IM
2How have developing countries benefitted?
INFECTS 216+ MILLION PEOPLE
KILLS AROUND 655,000 PEOPLE
Image Credit: Anne Heslop Photography
359 products in development43% involving European developers
FOR VACCINES ALONE, THERE ARE PROMISING CANDIDATES FOR BURULI ULCER, TUBERCULOSIS AND SCHISTOSOMIASIS
2How have developing countries benefitted?
Medical Research Council,Gambia
Medical Research Unit – Albert Schweitzer Hospital, Gabon
Ifakara Health Institute,Tanzania
Manhiça Health Research Centre, Mozambique
International Centre for Diarrhoeal Disease Research, Bangladesh
2How have developing countries benefitted?
Key Developing Country Research Institutions in Africa & Asia
EU investment created more than 13,000 jobs
3What is the return on investment for Europe?
Two-thirds of Europe’s PRND R&D funding is invested back into Europe
3What is the return on investment for Europe?
€1 €1€1.53€1.98€2.05
Industry €0.53
Philanthropy €0.45
Other gov’ts €0.07
3What is the return on investment for Europe?
Top European PRND Research Institutes
Institut Pasteur
Liverpool School of Tropical Medicine
London School of Hygiene & Tropical Medicine
Statens Serum Institute
Institute of Tropical Medicine
Swiss Tropical Institue of Public Health
Karolinska Institute
Royal Tropical Institute
Barcelona Centre for International Health Research
Heidelberg University
University of Tübingen
Bernhard Nocht Institute for Tropical Medicine
3What is the return on investment for Europe?
The European pharmaceutical industry invested six times more than the U.S. industry relative to annual revenues6
x
3What is the return on investment for Europe?
Opportunity:Horizon 2020
Increased PRND R&D investment under Horizon 2020 will benefit both developing countries and Europe
Opportunity:Horizon 2020
Collaboration & partnerships
Building Capacity in Developing Countries
Quality ResearchIntegrating Industry
=
+
+
+ +
Opportunity:Horizon 2020
EU Investment in PRND R&D
=Growth and competitiveness in the EU
Health and prosperity in developing countries
+
Recommendations
1Increase investments in PRND R&D including an increased commitment from the EC under Horizon 2020
Recommendations
2Retain and foster the distinctive benefits of its approach to funding PRND R&D
Recommendations
3Improve specific aspects of its investment in PRND R&D, to ensure greater efficiency, impact and value
Recommendations
Thank you